World's Best Scientists 2026 revealed!
Torsten Tonn

Torsten Tonn

D-Index & Metrics

Immunology

D-Index
63
Citations
19004
World Ranking
2989
National Ranking
200

Overview

Torsten Tonn is a researcher affiliated with TU Dresden in Germany, focusing on medical science with extensive work in infectious diseases, immunology, and oncology. Their research output includes studies on immune cell dynamics, viral infections, and immunotherapies.

The main fields of study for Torsten Tonn encompass Medicine, with subfields including Infectious Diseases, Immunology, Oncology, Genetics, and Molecular Biology. Their research explores complex interactions within the immune system and diseases affecting the blood and immune cells.

Key topics in their work cover:

  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Erythrocyte Function and Pathophysiology
  • T-cell and B-cell Immunology

Torsten Tonn has published in several specialized journals and publication venues, notably:

  • Cytotherapy
  • Neuro-Oncology
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Transfusion Medicine and Hemotherapy

Frequent co-authors collaborating with Tonn include:

  • Jaap Jan Boelens
  • Rachele Ciccocioppo
  • Ekaterina Doubrovina
  • Miguel Forte
  • Jacques Galipeau

Notable recent publications feature studies on SARS-CoV-2 immunity, COVID-19 patient prognostics, and cancer immunotherapy:

  • "Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine" (2021) published in The Lancet Regional Health - Europe
  • "SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care" (2021) published in Nature Communications
  • "Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma" (2020) published in Journal of Virological Methods
  • "Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma" (2023) published in Neuro-Oncology
  • "SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism" (2022) published in Stem Cell Reviews and Reports

Best Publications

  • Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

    Volker Schächinger;Sandra Erbs;Albrecht Elsässer;Werner Haberbosch

  • Transcoronary transplantation of progenitor cells after myocardial infarction.

    Birgit Assmus;Jörg Honold;Volker Schächinger;Martina B Britten

  • Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

  • Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

    Florian H. Seeger;Torsten Tonn;Nicola Krzossok;Andreas M. Zeiher

  • Treatment of patients with advanced cancer with the natural killer cell line NK-92

    Torsten Tonn;Torsten Tonn;Dirk Schwabe;Hans G. Klingemann;Sven Becker;Sven Becker

  • Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

    Birgit Assmus;Andreas Rolf;Sandra Erbs;Albrecht Elsässer

  • ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

    Congcong Zhang;Michael C. Burger;Lukas Jennewein;Sabrina Genßler

  • NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

    Garnet Suck;Marcus Odendahl;Paulina Nowakowska;Christian Seidl

  • Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

    Christoph Uherek;Torsten Tonn;Barbara Uherek;Sven Becker

  • Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.

    Torsten Tonn;Sven Becker;Ruth Esser;Dirk Schwabe

  • Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

    Kurt Schönfeld;Christiane Sahm;Congcong Zhang;Sonja Naundorf

  • Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)

    Dirk H. Walter;Hans Krankenberg;Jörn O. Balzer;Christoph Kalka

  • Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial

    Sandra Erbs;Axel Linke;Volker Schächinger;Birgit Assmus

  • Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

    Anita Schmitt;Torsten Tonn;Dirk H. Busch;Goetz Ulrich Grigoleit

  • Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry

    Birgit Assmus;Ulrich Fischer-Rasokat;Jörg Honold;Florian H. Seeger

  • Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

    Congcong Zhang;Pranav Oberoi;Sarah Oelsner;Anja Waldmann

  • Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

    Tina Müller;Christoph Uherek;Guitta Maki;Kai Uwe Chow

  • Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy

    Y.K. Tam;G. Maki;B. Miyagawa;B. Hennemann

  • Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.

    Julian Stumpf;Torsten Siepmann;Tom Lindner;Claudia Karger

  • CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies

    Annette Romanski;Christoph Uherek;Gesine Bug;Erhard Seifried

  • Applying extracellular vesicles based therapeutics in clinical trials

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

Frequent Co-Authors

Erhard Seifried
Erhard Seifried German Red Cross
Winfried S. Wels
Winfried S. Wels Goethe University Frankfurt
Andreas M. Zeiher
Andreas M. Zeiher Goethe University Frankfurt
Stefanie Dimmeler
Stefanie Dimmeler Goethe University Frankfurt
Halvard Bonig
Halvard Bonig Goethe University Frankfurt
Ulrike Koehl
Ulrike Koehl Leipzig University
Rainer Hambrecht
Rainer Hambrecht University of Lübeck
Roberto Corti
Roberto Corti University of Zurich
Christian W. Hamm
Christian W. Hamm University of Giessen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens multiple doors, especially when paired with strategic online programs that accelerate career growth in healthcare. For those interested in nursing roles, exploring an accelerated FNP program can fast-track your path to becoming a Family Nurse Practitioner, combining clinical expertise with immunology knowledge.

Additionally, if you are new to the nursing field, online nursing programs designed specifically for non-nurses provide a flexible route to enter the profession. These online nursing programs for non nurses focus on foundational skills while accommodating diverse backgrounds.

For those seeking a quicker entry point, enrolling in absn programs with high acceptance rates is a practical choice. These accelerated Bachelor of Science in Nursing programs minimize barriers to admission without sacrificing quality education, often integrating immunology courses relevant to patient care.

Moreover, certified practical nursing remains a vital healthcare role. Many choose accredited LPN programs easy to get into as an accessible step towards clinical practice, where a foundational understanding of immunology supports infection control and patient safety.

Best Scientists Citing Torsten Tonn

Trending Scientists

Recently Published Articles